关注
Yves Gruel
Yves Gruel
INSERM UMR1327 ISCHEMIA
在 med.univ-tours.fr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study
G Meyer, Z Marjanovic, J Valcke, B Lorcerie, Y Gruel, P Solal-Celigny, ...
Archives of internal medicine 162 (15), 1729-1735, 2002
10622002
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
A Cuker, GM Arepally, BH Chong, DB Cines, A Greinacher, Y Gruel, ...
Blood advances 2 (22), 3360-3392, 2018
6062018
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
P Knoebl, P Marco, F Baudo, P Collins, A Huth‐Kühne, L Nemes, ...
Journal of Thrombosis and Haemostasis 10 (4), 622-631, 2012
5792012
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals …
G Pernod, P Albaladejo, A Godier, CM Samama, S Susen, Y Gruel, ...
Archives of cardiovascular diseases 106 (6-7), 382-393, 2013
3702013
Antibodies to platelet factor 4–heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: clinical …
C Pouplard, MA May, S Iochmann, J Amiral, AM Vissac, M Marchand, ...
Circulation 99 (19), 2530-2536, 1999
3621999
Evolution of blood coagulation activators and inhibitors in the healthy human fetus
P Reverdiau-Moalic, B Delahousse, G Body, P Bardos, J Leroy, Y Gruel
3061996
Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent
JC Gris, I Quéré, F Monpeyrou, E Mercier, S Ripart-Neveu, ML Tailland, ...
Thrombosis and haemostasis 81 (06), 891-899, 1999
3011999
Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis
G Cayla, JS Hulot, SA O’Connor, A Pathak, SA Scott, Y Gruel, J Silvain, ...
Jama 306 (16), 1765-1774, 2011
2692011
Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin
P Savi, BH Chong, A Greinacher, Y Gruel, JG Kelton, TE Warkentin, ...
Blood 105 (1), 139-144, 2005
2492005
Induction of monocyte tissue factor expression by antibodies to heparin–platelet factor 4 complexes developed in heparin-induced thrombocytopenia
C Pouplard, S Iochmann, B Renard, O Herault, P Colombat, J Amiral, ...
Blood, The Journal of the American Society of Hematology 97 (10), 3300-3302, 2001
2372001
Prospective evaluation of the ‘4Ts’ score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin‐induced thrombocytopenia
C Pouplard, P Gueret, M Fouassier, C Ternisien, M Trossaert, S Regina, ...
Journal of Thrombosis and Haemostasis 5 (7), 1373-1379, 2007
2312007
Decision analysis for use of platelet aggregation test, Carbon 14–Serotonin release assay, and heparin–platelet factor 4 Enzyme-Linked immunosorbent assay for diagnosis of …
C Pouplard, J Amiral, JY Borg, S Laporte-Simitsidis, B Delahousse, ...
American journal of clinical pathology 111 (5), 700-706, 1999
2291999
Voltage-gated sodium channels potentiate the invasive capacities of human non-small-cell lung cancer cell lines
S Roger, J Rollin, A Barascu, P Besson, PI Raynal, S Iochmann, M Lei, ...
The international journal of biochemistry & cell biology 39 (4), 774-786, 2007
2162007
Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin‐dependent antibodies
C Pouplard, MA May, S Regina, M Marchand, J Fusciardi, Y Gruel
British journal of haematology 128 (6), 837-841, 2005
2102005
Determination of platelet antigens and glycoproteins in the human fetus
Y Gruel, B Boizard, F Daffos, F Forestier, J Caen, JL Wautier
1831986
Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma …
M Hunault-Berger, P Chevallier, M Delain, CE Bulabois, S Bologna, ...
haematologica 93 (10), 1488-1494, 2008
1812008
Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring
S Susen, CA Tacquard, A Godon, A Mansour, D Garrigue, P Nguyen, ...
Critical care 24 (1), 364, 2020
1692020
Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY 216)
J Leroy, MH Leclerc, B Delahousse, C Guerois, P Foloppe, Y Gruel, ...
Seminars in thrombosis and hemostasis 11 (03), 326-329, 1985
1591985
Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer
J Rollin, S Régina, P Vourc’h, S Iochmann, C Bléchet, P Reverdiau, ...
Lung cancer 56 (2), 273-280, 2007
1492007
Laboratory testing for heparin‐induced thrombocytopenia: a conceptual framework and implications for diagnosis
TE Warkentin, A Greinacher, Y Gruel, RH Aster, BH Chong
Journal of Thrombosis and Haemostasis 9 (12), 2498-2500, 2011
1402011
系统目前无法执行此操作,请稍后再试。
文章 1–20